| HGNC Family | EF-hand domain containing |
| Name | visinin-like 1 |
| Description | This gene is a member of the visinin/recoverin subfamily of neuronal calcium sensor proteins. The encoded protein is strongly expressed in granule cells of the cerebellum where it associates with membranes in a calcium-dependent manner and modulates intracellular signaling pathways of the central nervous system by directly or indirectly regulating the activity of adenylyl cyclase. Alternatively spliced transcript variants have been observed, but their full-length nature has not been determined. [provided by RefSeq, Jul 2008] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nVSNL1, also known as visinin‐like protein–1 (VILIP–1), is a neuronal calcium sensor protein that plays a pivotal role in modulating intracellular signaling via its calcium–myristoyl switch mechanism. Calcium binding induces a conformational change that promotes its reversible association with membranes, thereby regulating the trafficking and function of key receptors. For instance, VSNL1 modulates the surface expression and agonist sensitivity of α4β2 nicotinic acetylcholine receptors and influences purinergic (P2X2) receptor activity, leading to downstream changes in cyclic AMP and cyclic GMP levels. In addition, VSNL1 participates in synaptic plasticity, cytoskeletal interactions, and dendritic remodeling, processes critical to normal neuronal circuitry and excitability."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "14"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn recent years VSNL1 has emerged as a valuable biomarker for neurodegenerative and acute neurological conditions. Elevated cerebrospinal fluid levels of VSNL1 have been closely associated with Alzheimer’s disease pathology, and ratios involving VSNL1 (for example, relative to amyloid‐β and phosphorylated tau species) help differentiate Alzheimer’s disease from other dementias such as dementia with Lewy bodies. In addition, altered VSNL1 expression has been documented in settings of acute neuronal injury—including stroke, acute encephalopathy with biphasic seizures, and other brain injuries—underscoring its potential utility for early diagnosis, prognostication, and monitoring of disease progression."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "15", "end_ref": "23"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond its neuronal roles, VSNL1 also exerts important regulatory effects in non‐neuronal tissues and disease contexts. In endocrine and cardiovascular systems, for example, VSNL1 influences hormone synthesis in adrenal cells and modulates glucose–dependent insulin secretion in pancreatic β–cells through cAMP–mediated signaling. In oncological settings, reduced or aberrant VSNL1 expression has been linked to tumor progression and metastasis in various cancers—including non–small cell lung cancer, colorectal cancer, neuroblastoma, and medulloblastoma—where it can act as a tumor suppressor or modulator of cell invasiveness. Moreover, emerging evidence indicates that VSNL1 may interface with pathways such as Wnt/β–catenin signaling, further broadening its impact on cell proliferation, differentiation, and survival in diverse cellular contexts."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "24", "end_ref": "33"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "S E Lenz, K H Braunewell, C Weise, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The neuronal EF-hand Ca(2+)-binding protein VILIP: interaction with cell membrane and actin-based cytoskeleton."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (1996)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1006/bbrc.1996.1298"}], "href": "https://doi.org/10.1006/bbrc.1996.1298"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "8780737"}], "href": "https://pubmed.ncbi.nlm.nih.gov/8780737"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "K H Braunewell, C Spilker, T Behnisch, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The neuronal calcium-sensor protein VILIP modulates cyclic AMP accumulation in stably transfected C6 glioma cells: amino-terminal myristoylation determines functional activity."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Neurochem (1997)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1046/j.1471-4159.1997.68052129.x"}], "href": "https://doi.org/10.1046/j.1471-4159.1997.68052129.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "9109541"}], "href": "https://pubmed.ncbi.nlm.nih.gov/9109541"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "K H Braunewell, M Brackmann, M Schaupp, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Intracellular neuronal calcium sensor (NCS) protein VILIP-1 modulates cGMP signalling pathways in transfected neural cells and cerebellar granule neurones."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Neurochem (2001)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1046/j.1471-4159.2001.00506.x"}], "href": "https://doi.org/10.1046/j.1471-4159.2001.00506.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "11579136"}], "href": "https://pubmed.ncbi.nlm.nih.gov/11579136"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "I Schnurra, H G Bernstein, P Riederer, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The neuronal calcium sensor protein VILIP-1 is associated with amyloid plaques and extracellular tangles in Alzheimer's disease and promotes cell death and tau phosphorylation in vitro: a link between calcium sensors and Alzheimer's disease?"}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neurobiol Dis (2001)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1006/nbdi.2001.0432"}], "href": "https://doi.org/10.1006/nbdi.2001.0432"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "11592857"}], "href": "https://pubmed.ncbi.nlm.nih.gov/11592857"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Hans-Gert Bernstein, Karl-Heinz Braunewell, Christina Spilker, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Hippocampal expression of the calcium sensor protein visinin-like protein-1 in schizophrenia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neuroreport (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/00001756-200203250-00006"}], "href": "https://doi.org/10.1097/00001756-200203250-00006"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "11930147"}], "href": "https://pubmed.ncbi.nlm.nih.gov/11930147"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Christina Spilker, Thomas Dresbach, Karl-Heinz Braunewell "}, {"type": "b", "children": [{"type": "t", "text": "Reversible translocation and activity-dependent localization of the calcium-myristoyl switch protein VILIP-1 to different membrane compartments in living hippocampal neurons."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Neurosci (2002)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12196554"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12196554"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Lin Lin, Elisabeth M Jeanclos, Magdalen Treuil, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The calcium sensor protein visinin-like protein-1 modulates the surface expression and agonist sensitivity of the alpha 4beta 2 nicotinic acetylcholine receptor."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M206857200"}], "href": "https://doi.org/10.1074/jbc.M206857200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12202488"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12202488"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "K-H Braunewell, M Brackmann, D Manahan-Vaughan "}, {"type": "b", "children": [{"type": "t", "text": "Group I mGlu receptors regulate the expression of the neuronal calcium sensor protein VILIP-1 in vitro and in vivo: implications for mGlu receptor-dependent hippocampal plasticity?"}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neuropharmacology (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/s0028-3908(03)00051-0"}], "href": "https://doi.org/10.1016/s0028-3908(03"}, {"type": "t", "text": "00051-0) PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12681369"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12681369"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Feng-Fin Jheng, Likuan Wang, Liya Lee, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Functional contribution of Ca2+ and Mg2+ to the intermolecular interaction of visinin-like proteins."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Protein J (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s10930-006-9008-5"}], "href": "https://doi.org/10.1007/s10930-006-9008-5"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16703469"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16703469"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Severine Chaumont, Vincent Compan, Estelle Toulme, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Regulation of P2X2 receptors by the neuronal calcium sensor VILIP1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Signal (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1126/scisignal.1162329"}], "href": "https://doi.org/10.1126/scisignal.1162329"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18922787"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18922787"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "C J Zhao, C Noack, M Brackmann, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Neuronal Ca2+ sensor VILIP-1 leads to the upregulation of functional alpha4beta2 nicotinic acetylcholine receptors in hippocampal neurons."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell Neurosci (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.mcn.2008.11.001"}], "href": "https://doi.org/10.1016/j.mcn.2008.11.001"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19063970"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19063970"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Congmin Li, Wensheng Pan, Karl H Braunewell, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Structural analysis of Mg2+ and Ca2+ binding, myristoylation, and dimerization of the neuronal calcium sensor and visinin-like protein 1 (VILIP-1)."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M110.173724"}], "href": "https://doi.org/10.1074/jbc.M110.173724"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21169352"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21169352"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "K H Braunewell, A D Dwary, F Richter, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Association of VSNL1 with schizophrenia, frontal cortical function, and biological significance for its gene product as a modulator of cAMP levels and neuronal morphology."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Transl Psychiatry (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/tp.2011.20"}], "href": "https://doi.org/10.1038/tp.2011.20"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22832524"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22832524"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Samuel Rebaud, Conan K Wang, Joe Sarkis, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Specific interaction to PIP2 increases the kinetic rate of membrane binding of VILIPs, a subfamily of Neuronal Calcium Sensors (NCS) proteins."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochim Biophys Acta (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbamem.2014.06.021"}], "href": "https://doi.org/10.1016/j.bbamem.2014.06.021"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25019684"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25019684"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Rawan Tarawneh, Gina D'Angelo, Elizabeth Macy, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Visinin-like protein-1: diagnostic and prognostic biomarker in Alzheimer disease."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Ann Neurol (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/ana.22448"}], "href": "https://doi.org/10.1002/ana.22448"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21823155"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21823155"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "P Hollingworth, R Sweet, R Sims, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Genome-wide association study of Alzheimer's disease with psychotic symptoms."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Psychiatry (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/mp.2011.125"}], "href": "https://doi.org/10.1038/mp.2011.125"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22005930"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22005930"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "R Tarawneh, J-M Lee, J H Ladenson, et al. "}, {"type": "b", "children": [{"type": "t", "text": "CSF VILIP-1 predicts rates of cognitive decline in early Alzheimer disease."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neurology (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1212/WNL.0b013e318248e568"}], "href": "https://doi.org/10.1212/WNL.0b013e318248e568"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22357717"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22357717"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Xinni Luo, Le Hou, Haishan Shi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "CSF levels of the neuronal injury biomarker visinin-like protein-1 in Alzheimer's disease and dementia with Lewy bodies."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Neurochem (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/jnc.12331"}], "href": "https://doi.org/10.1111/jnc.12331"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23800322"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23800322"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Shunji Hasegawa, Takeshi Matsushige, Hirofumi Inoue, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Serum and cerebrospinal fluid levels of visinin-like protein-1 in acute encephalopathy with biphasic seizures and late reduced diffusion."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Brain Dev (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.braindev.2013.08.010"}], "href": "https://doi.org/10.1016/j.braindev.2013.08.010"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24075506"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24075506"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Mirjana Babić Leko, Fran Borovečki, Nenad Dejanović, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Predictive Value of Cerebrospinal Fluid Visinin-Like Protein-1 Levels for Alzheimer's Disease Early Detection and Differential Diagnosis in Patients with Mild Cognitive Impairment."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Alzheimers Dis (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3233/JAD-150705"}], "href": "https://doi.org/10.3233/JAD-150705"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26836160"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26836160"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Abdullah Algin, M Ozgur Erdogan, Irfan Aydin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Clinical usefulness of brain-derived neurotrophic factor and visinin-like protein-1 in early diagnostic tests for acute stroke."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Emerg Med (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ajem.2019.02.037"}], "href": "https://doi.org/10.1016/j.ajem.2019.02.037"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30826210"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30826210"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Xin-Jiang Yan, Yang-Bo Li, Wei Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Predictive value of serum visinin-like protein-1 for early neurologic deterioration and three-month clinical outcome in acute primary basal ganglia hemorrhage: A prospective and observational study."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Chim Acta (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.cca.2022.03.008"}], "href": "https://doi.org/10.1016/j.cca.2022.03.008"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35292254"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35292254"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Steffen Halbgebauer, Petra Steinacker, Daniel Riedel, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Visinin-like protein 1 levels in blood and CSF as emerging markers for Alzheimer's and other neurodegenerative diseases."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Alzheimers Res Ther (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s13195-022-01122-4"}], "href": "https://doi.org/10.1186/s13195-022-01122-4"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "36419075"}], "href": "https://pubmed.ncbi.nlm.nih.gov/36419075"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Feihan F Dai, Yi Zhang, Youhou Kang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The neuronal Ca2+ sensor protein visinin-like protein-1 is expressed in pancreatic islets and regulates insulin secretion."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M512924200"}], "href": "https://doi.org/10.1074/jbc.M512924200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16731532"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16731532"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Yi Xie, Hiuman Chan, Jianqing Fan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Involvement of visinin-like protein-1 (VSNL-1) in regulating proliferative and invasive properties of neuroblastoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Carcinogenesis (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/carcin/bgm147"}], "href": "https://doi.org/10.1093/carcin/bgm147"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17615261"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17615261"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Jian Fu, Kathryn Fong, Alfonso Bellacosa, et al. "}, {"type": "b", "children": [{"type": "t", "text": "VILIP-1 downregulation in non-small cell lung carcinomas: mechanisms and prediction of survival."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0001698"}], "href": "https://doi.org/10.1371/journal.pone.0001698"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18301774"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18301774"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Jens Buttgereit, Fatimunnisa Qadri, Jan Monti, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Visinin-like protein 1 regulates natriuretic peptide receptor B in the heart."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Regul Pept (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.regpep.2009.12.019"}], "href": "https://doi.org/10.1016/j.regpep.2009.12.019"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20079378"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20079378"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Tracy Ann Williams, Silvia Monticone, Valentina Crudo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Visinin-like 1 is upregulated in aldosterone-producing adenomas with KCNJ5 mutations and protects from calcium-induced apoptosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hypertension (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1161/HYPERTENSIONAHA.111.188532"}], "href": "https://doi.org/10.1161/HYPERTENSIONAHA.111.188532"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22331379"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22331379"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Martina P Liebl, Ali M Kaya, Stefan Tenzer, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Dimerization of visinin-like protein 1 is regulated by oxidative stress and calcium and is a pathological hallmark of amyotrophic lateral sclerosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Free Radic Biol Med (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.freeradbiomed.2014.04.008"}], "href": "https://doi.org/10.1016/j.freeradbiomed.2014.04.008"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24742816"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24742816"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Davide Barbagallo, Angelo Condorelli, Marco Ragusa, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Dysregulated miR-671-5p / CDR1-AS / CDR1 / VSNL1 axis is involved in glioblastoma multiforme."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.6621"}], "href": "https://doi.org/10.18632/oncotarget.6621"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26683098"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26683098"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Andrey Korshunov, Konstantin Okonechnikov, Felix Sahm, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Transcriptional profiling of medulloblastoma with extensive nodularity (MBEN) reveals two clinically relevant tumor subsets with VSNL1 as potent prognostic marker."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Acta Neuropathol (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00401-019-02102-z"}], "href": "https://doi.org/10.1007/s00401-019-02102-z"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31781912"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31781912"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "Chuan He, Weiguo Liu, Yan Xiong, et al. "}, {"type": "b", "children": [{"type": "t", "text": "VSNL1 Promotes Cell Proliferation, Migration, and Invasion in Colorectal Cancer by Binding with COL10A1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Ann Clin Lab Sci (2022)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35181619"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35181619"}]}, {"type": "r", "ref": 33, "children": [{"type": "t", "text": "Hiroki Tage, Kiyoshi Yamaguchi, Saya Nakagawa, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Visinin-like 1, a novel target gene of the Wnt/β-catenin signaling pathway, is involved in apoptosis resistance in colorectal cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Med (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/cam4.5970"}], "href": "https://doi.org/10.1002/cam4.5970"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "37096864"}], "href": "https://pubmed.ncbi.nlm.nih.gov/37096864"}]}]}]}
|
| Synonyms | HUVISL1, VILIP-1, VILIP, HPCAL3 |
| Proteins | VISL1_HUMAN |
| NCBI Gene ID | 7447 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
VSNL1 has 6,930 functional associations with biological entities spanning 9 categories (molecular profile, organism, chemical, functional term, phrase or reference, disease, phenotype or trait, structural feature, cell line, cell type or tissue, gene, protein or microRNA, sequence feature) extracted from 107 datasets.
Click the + buttons to view associations for VSNL1 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of VSNL1 gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles | tissues with high or low expression of VSNL1 gene relative to other tissues from the Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of VSNL1 gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray | tissue samples with high or low expression of VSNL1 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq | tissue samples with high or low expression of VSNL1 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq dataset. | |
| Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of VSNL1 gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset. | |
| BioGPS Cell Line Gene Expression Profiles | cell lines with high or low expression of VSNL1 gene relative to other cell lines from the BioGPS Cell Line Gene Expression Profiles dataset. | |
| BioGPS Human Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of VSNL1 gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset. | |
| BioGPS Mouse Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of VSNL1 gene relative to other cell types and tissues from the BioGPS Mouse Cell Type and Tissue Gene Expression Profiles dataset. | |
| Carcinogenome Chemical Perturbation Carcinogenicity Signatures | small molecule perturbations changing expression of VSNL1 gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset. | |
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of VSNL1 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| CCLE Cell Line Gene Expression Profiles | cell lines with high or low expression of VSNL1 gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset. | |
| CCLE Cell Line Proteomics | Cell lines associated with VSNL1 protein from the CCLE Cell Line Proteomics dataset. | |
| CellMarker Gene-Cell Type Associations | cell types associated with VSNL1 gene from the CellMarker Gene-Cell Type Associations dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of VSNL1 gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of VSNL1 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| ChEA Transcription Factor Targets 2022 | transcription factors binding the promoter of VSNL1 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset. | |
| CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of VSNL1 gene from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores | cellular components co-occuring with VSNL1 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with VSNL1 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
| CORUM Protein Complexes | protein complexs containing VSNL1 protein from the CORUM Protein Complexes dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of VSNL1 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| COSMIC Cell Line Gene Mutation Profiles | cell lines with VSNL1 gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset. | |
| CTD Gene-Chemical Interactions | chemicals interacting with VSNL1 gene/protein from the curated CTD Gene-Chemical Interactions dataset. | |
| CTD Gene-Disease Associations | diseases associated with VSNL1 gene/protein from the curated CTD Gene-Disease Associations dataset. | |
| dbGAP Gene-Trait Associations | traits associated with VSNL1 gene in GWAS and other genetic association datasets from the dbGAP Gene-Trait Associations dataset. | |
| DeepCoverMOA Drug Mechanisms of Action | small molecule perturbations with high or low expression of VSNL1 protein relative to other small molecule perturbations from the DeepCoverMOA Drug Mechanisms of Action dataset. | |
| DepMap CRISPR Gene Dependency | cell lines with fitness changed by VSNL1 gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset. | |
| DISEASES Experimental Gene-Disease Association Evidence Scores | diseases associated with VSNL1 gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores | diseases co-occuring with VSNL1 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with VSNL1 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DisGeNET Gene-Disease Associations | diseases associated with VSNL1 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. | |
| DisGeNET Gene-Phenotype Associations | phenotypes associated with VSNL1 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at VSNL1 gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of VSNL1 gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of VSNL1 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| ESCAPE Omics Signatures of Genes and Proteins for Stem Cells | PubMedIDs of publications reporting gene signatures containing VSNL1 from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset. | |
| GAD Gene-Disease Associations | diseases associated with VSNL1 gene in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. | |
| GAD High Level Gene-Disease Associations | diseases associated with VSNL1 gene in GWAS and other genetic association datasets from the GAD High Level Gene-Disease Associations dataset. | |
| GDSC Cell Line Gene Expression Profiles | cell lines with high or low expression of VSNL1 gene relative to other cell lines from the GDSC Cell Line Gene Expression Profiles dataset. | |
| GeneRIF Biological Term Annotations | biological terms co-occuring with VSNL1 gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. | |
| GeneSigDB Published Gene Signatures | PubMedIDs of publications reporting gene signatures containing VSNL1 from the GeneSigDB Published Gene Signatures dataset. | |
| GEO Signatures of Differentially Expressed Genes for Diseases | disease perturbations changing expression of VSNL1 gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of VSNL1 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Kinase Perturbations | kinase perturbations changing expression of VSNL1 gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of VSNL1 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations | transcription factor perturbations changing expression of VSNL1 gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Viral Infections | virus perturbations changing expression of VSNL1 gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset. | |
| GO Biological Process Annotations 2015 | biological processes involving VSNL1 gene from the curated GO Biological Process Annotations 2015 dataset. | |
| GO Biological Process Annotations 2025 | biological processes involving VSNL1 gene from the curated GO Biological Process Annotations2025 dataset. | |
| GO Molecular Function Annotations 2015 | molecular functions performed by VSNL1 gene from the curated GO Molecular Function Annotations 2015 dataset. | |
| GO Molecular Function Annotations 2023 | molecular functions performed by VSNL1 gene from the curated GO Molecular Function Annotations 2023 dataset. | |
| GO Molecular Function Annotations 2025 | molecular functions performed by VSNL1 gene from the curated GO Molecular Function Annotations 2025 dataset. | |
| GTEx eQTL 2025 | SNPs regulating expression of VSNL1 gene from the GTEx eQTL 2025 dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of VSNL1 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of VSNL1 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
| GTEx Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of VSNL1 gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset. | |
| GWAS Catalog SNP-Phenotype Associations | phenotypes associated with VSNL1 gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations dataset. | |
| GWAS Catalog SNP-Phenotype Associations 2025 | phenotypes associated with VSNL1 gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset. | |
| GWASdb SNP-Disease Associations | diseases associated with VSNL1 gene in GWAS and other genetic association datasets from the GWASdb SNP-Disease Associations dataset. | |
| GWASdb SNP-Phenotype Associations | phenotypes associated with VSNL1 gene in GWAS datasets from the GWASdb SNP-Phenotype Associations dataset. | |
| Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles | cell lines with high or low expression of VSNL1 gene relative to other cell lines from the Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles dataset. | |
| HMDB Metabolites of Enzymes | interacting metabolites for VSNL1 protein from the curated HMDB Metabolites of Enzymes dataset. | |
| HPA Cell Line Gene Expression Profiles | cell lines with high or low expression of VSNL1 gene relative to other cell lines from the HPA Cell Line Gene Expression Profiles dataset. | |
| HPA Tissue Gene Expression Profiles | tissues with high or low expression of VSNL1 gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset. | |
| HPA Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of VSNL1 gene relative to other tissue samples from the HPA Tissue Sample Gene Expression Profiles dataset. | |
| Hub Proteins Protein-Protein Interactions | interacting hub proteins for VSNL1 from the curated Hub Proteins Protein-Protein Interactions dataset. | |
| HuGE Navigator Gene-Phenotype Associations | phenotypes associated with VSNL1 gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset. | |
| InterPro Predicted Protein Domain Annotations | protein domains predicted for VSNL1 protein from the InterPro Predicted Protein Domain Annotations dataset. | |
| JASPAR Predicted Human Transcription Factor Targets 2025 | transcription factors regulating expression of VSNL1 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset. | |
| JASPAR Predicted Mouse Transcription Factor Targets 2025 | transcription factors regulating expression of VSNL1 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of VSNL1 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of VSNL1 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles | cell lines with VSNL1 gene mutations from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles dataset. | |
| KnockTF Gene Expression Profiles with Transcription Factor Perturbations | transcription factor perturbations changing expression of VSNL1 gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset. | |
| LINCS L1000 CMAP Chemical Perturbation Consensus Signatures | small molecule perturbations changing expression of VSNL1 gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset. | |
| LINCS L1000 CMAP CRISPR Knockout Consensus Signatures | gene perturbations changing expression of VSNL1 gene from the LINCS L1000 CMAP CRISPR Knockout Consensus Signatures dataset. | |
| LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of VSNL1 gene from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| LOCATE Curated Protein Localization Annotations | cellular components containing VSNL1 protein in low- or high-throughput protein localization assays from the LOCATE Curated Protein Localization Annotations dataset. | |
| LOCATE Predicted Protein Localization Annotations | cellular components predicted to contain VSNL1 protein from the LOCATE Predicted Protein Localization Annotations dataset. | |
| MiRTarBase microRNA Targets | microRNAs targeting VSNL1 gene in low- or high-throughput microRNA targeting studies from the MiRTarBase microRNA Targets dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of VSNL1 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| MoTrPAC Rat Endurance Exercise Training | tissue samples with high or low expression of VSNL1 gene relative to other tissue samples from the MoTrPAC Rat Endurance Exercise Training dataset. | |
| MSigDB Cancer Gene Co-expression Modules | co-expressed genes for VSNL1 from the MSigDB Cancer Gene Co-expression Modules dataset. | |
| MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations | gene perturbations changing expression of VSNL1 gene from the MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations dataset. | |
| Pathway Commons Protein-Protein Interactions | interacting proteins for VSNL1 from the Pathway Commons Protein-Protein Interactions dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of VSNL1 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Mouse Gene Perturbations | gene perturbations changing expression of VSNL1 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PFOCR Pathway Figure Associations 2023 | pathways involving VSNL1 protein from the PFOCR Pathway Figure Associations 2023 dataset. | |
| PFOCR Pathway Figure Associations 2024 | pathways involving VSNL1 protein from the Wikipathways PFOCR 2024 dataset. | |
| Roadmap Epigenomics Cell and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of VSNL1 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue Gene Expression Profiles dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at VSNL1 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of VSNL1 gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of VSNL1 gene from the RummaGEO Gene Perturbation Signatures dataset. | |
| Sanger Dependency Map Cancer Cell Line Proteomics | cell lines associated with VSNL1 protein from the Sanger Dependency Map Cancer Cell Line Proteomics dataset. | |
| Tabula Sapiens Gene-Cell Associations | cell types with high or low expression of VSNL1 gene relative to other cell types from the Tabula Sapiens Gene-Cell Associations dataset. | |
| Tahoe Therapeutics Tahoe 100M Perturbation Atlas | drug perturbations changing expression of VSNL1 gene from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset. | |
| TargetScan Predicted Conserved microRNA Targets | microRNAs regulating expression of VSNL1 gene predicted using conserved miRNA seed sequences from the TargetScan Predicted Conserved microRNA Targets dataset. | |
| TargetScan Predicted Nonconserved microRNA Targets | microRNAs regulating expression of VSNL1 gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset. | |
| TCGA Signatures of Differentially Expressed Genes for Tumors | tissue samples with high or low expression of VSNL1 gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores | tissues with high expression of VSNL1 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of VSNL1 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores | tissues with high expression of VSNL1 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of VSNL1 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores | tissues co-occuring with VSNL1 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with VSNL1 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |
| WikiPathways Pathways 2014 | pathways involving VSNL1 protein from the Wikipathways Pathways 2014 dataset. | |